Input Stories

Input Stories

FDA: COVID-19 Vaccines Effective for Kids Under 5

An FDA announcement means COVID-19 vaccines are one step closer to being approved for young children, according to AP News.

  • Pfizer: The FDA reported on Sunday that Pfizer’s kid version of the COVID-19 vaccine appears to be safe and effective for kids younger than 5.
  • Moderna: Last week, the FDA released a similarly positive analysis about Moderna’s shots for children under 6.

Eligibility: Kids younger than 5 are the only group not eligible for COVID-19 vaccinations in the U.S. If the kid-sized doses are approved, 18 million babies, toddlers and preschoolers will become eligible for COVID-19 vaccination.

What’s next: On Wednesday, the FDA will make its official decision after an independent panel of vaccine experts debates both companies’ data.

  • Assuming the FDA votes “yes,” the CDC will convene its own panel and make recommendations on how to use the vaccines.
  • If regulators approve the shots, vaccinations could begin as soon as next week with drugmakers ready to quickly ship doses ordered by the government.

Why it matters: Experts say vaccinating America’s youngest children is important because COVID-19 hospitalization and death rates are higher in that group than among older children.

In related news: A vaccine designed to fight the omicron variant of COVID-19 produced a strong response in two new studies, offering new tools to fight the virus amid continuing mutations, according to The Wall Street Journal (subscription). Sanofi and GSK developed the vaccine.

View More